Impact of Remission Induction Chemotherapy Prior to Allogeneic SCT in Relapsed and Poor-response Patients With AML
Clinical trial NCT02461537 · COMPLETED
Trial details
- NCT number
- NCT02461537
- Sponsor
- DKMS gemeinnützige GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-17
- Primary completion
- 2022-04-05
- Enrollment
- 281
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.